title: Letter: A case of generalized guttate psoriasis induced by etanercept with relapse after abatacept.
abstract: Abatacept is the first in a new class of agents for the treatment of rheumatoid arthritis. We report a case of guttate psoriasis in a patient treated with abatacept for rheumatoid arthritis. This patient had the same reaction with etanercept in the past.
authors.forename: F
authors.initials: F
authors.lastname: Brigant
authors.forename: G
authors.initials: G
authors.lastname: Clavel
authors.forename: D
authors.initials: D
authors.lastname: Chatelain
authors.forename: C
authors.initials: C
authors.lastname: Lok
authors.forename: G
authors.initials: G
authors.lastname: Chaby
mesh_terms: D000069594:Abatacept; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D000068800:Etanercept; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects* / Q000627:therapeutic use; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D000069283:Rituximab; D013256:Steroids / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D018796:Immunoconjugates; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D013256:Steroids; D000069283:Rituximab; D000069594:Abatacept; D000068800:Etanercept; D008727:Methotrexate